Publications by authors named "Ines Bork"

Claim this Profile
L
Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients.
Bernd Schmidt, Dana Reinicke, Iris Reindl, Ines Bork, Bettina Wollschläger

Clin Chim Acta· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients" [Clin. Chim. Acta 469 (2017) 94-98].
Bernd Schmidt, Dana Reinicke, Iris Reindl, Ines Bork, Bettina Wollschläger

Clin Chim Acta· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.
Bernd Schmidt, Julia Beyer, Dimo Dietrich, Ines Bork, Volker Liebenberg

PLoS One· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of gemcitabine/irinotecan in refractory or relapsed small-cell lung cancer.
Wolfgang Schuette, Sylke Nagel, Stefan Juergens, Ines Bork, Bettina Wollschlaeger

Clin Lung Cancer· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma.
Wolfgang Schutte, Thomas Blankenburg, Kathrin Lauerwald, Jens Schreiber, Ines Bork

Clin Lung Cancer· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis